BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
3/14/2019 12:55:48 AM | Browse: 1031 | Download: 1949
 |
Received |
|
2018-12-05 06:21 |
|
Peer-Review Started |
|
2018-12-06 09:55 |
|
To Make the First Decision |
|
2019-01-07 02:57 |
|
Return for Revision |
|
2019-01-08 01:45 |
|
Revised |
|
2019-01-16 06:10 |
|
Second Decision |
|
2019-01-18 11:35 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2019-01-18 23:09 |
|
Articles in Press |
|
2019-01-18 23:09 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2019-03-13 00:42 |
|
Publish the Manuscript Online |
|
2019-03-14 00:55 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn’s disease patients
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Alice Jane Foster, Matthew Smyth, Alam Lakhani, Benjamin Jung, Brand F Rollin and Kevan Jacobson |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Lutsky Foundation |
|
| AbbVie Canada |
|
|
| Corresponding Author |
Kevan Jacobson, FRCP (C), MD, Doctor, Doctor, Professor, Senior Scientist, Division of Gastroenterology, Hepatology and Nutrition, British Columbia Children's Hospital, 4480 Oak Street, Room K4-181, Vancouver V6H 3V4, BC, Canada. kjacobson@cw.bc.ca |
| Key Words |
Fecal calprotectin; Disease relapse; Biomarker; Crohn’s disease; Children |
| Core Tip |
It has becoming increasingly evident that many children with Crohn’s disease who are in clinical remission continue to have ongoing active intestinal inflammation. This prospective paediatric study demonstrates the utility of fecal calprotectin monitoring in asymptomatic children with Crohn’s Disease. In this study, a significant number of children were found to have elevated levels despite clinical remission, and levels of > 250 μg/g were found to be a good predictor of clinical relapse in the subsequent 3 mo. |
| Publish Date |
2019-03-14 00:55 |
| Citation |
Foster AJ, Smyth M, Lakhani A, Jung B, Brant RF, Consecutive fecal calprotectin measurements for predicting relapse in pediatric Crohn’s disease patients. World J Gastroenterol 2019; 25(10): 1266-1277 |
| URL |
https://www.wjgnet.com/1007-9327/full/v25/i10/1266.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v25.i10.1266 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
